Class II · ModerateRecall completed
PANTOPRAZOLE 30MG IN NS 7.5ML
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberBeyond Use Date: December 29, 2022
Where it was soldDispensed to Patients Nationwide.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Lack of sterility assurance
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
| Distributed by / for | Sentara Infusion Services |
Show the full FDA record
| Full product label | PANTOPRAZOLE 30MG IN NS 7.5ML, SYRINGE, antimetic, Rx only, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320 |
| Recalling firm | Sentara Infusion Services |
| Distribution | Dispensed to Patients Nationwide. |
| Quantity | 14 bags |
| Recall initiated | 2022-12-27 |
| Report date | 2023-02-22 |
| Recall completed | 2026-02-20 |
| Recall number | D-0313-2023 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Chesapeake VA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.